Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytotoxic Drug”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04554914
What this trial is testing

Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

Who this might be right for
Epstein-Barr Virus (EBV)-Associated DiseasesEBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD)EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD)+8 more
Pierre Fabre Medicament 190
Very early researchUnknownNCT03060343
What this trial is testing

Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Yu Fenglei 10
Not applicableEnded earlyNCT02213432
What this trial is testing

Influenza Vaccination in Cancer Patients

Who this might be right for
Cancer
Seoul National University Hospital 97
Testing effectiveness (Phase 2)Study completedNCT01896869
What this trial is testing

FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 83
Testing effectiveness (Phase 2)Study completedNCT00001256
What this trial is testing

Steroids and Methotrexate to Treat Systemic Vasculitis

Who this might be right for
InflammationVasculitisWegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID) 100
Post-approval studies (Phase 4)Study completedNCT03004261
What this trial is testing

CMV-CTL for the Treatment of CMV Infection After HSCT

Who this might be right for
Cytomegalovirus InfectionsHematological Disease
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 5
Testing effectiveness (Phase 2)Ended earlyNCT02677688
What this trial is testing

Autologous EBV-specific Cytotoxic T Cells for the Treatment of Systemic Lupus Erythematosus (SLE)

Who this might be right for
Serologically Active Adult Systemic Lupus Erythematosus
Nantes University Hospital 9
Not applicableStudy completedNCT01789983
What this trial is testing

Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy

Who this might be right for
Breast CancerColon CancerLung Cancer
UNC Lineberger Comprehensive Cancer Center 29
Early research (Phase 1)Study completedNCT03849469
What this trial is testing

XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Who this might be right for
MelanomaCervical CarcinomaPancreatic Carcinoma+20 more
Xencor, Inc. 78
Not applicableNo Longer AvailableNCT02822495
What this trial is testing

Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

Who this might be right for
Epstein-Barr Virus (EBV) InfectionsLymphoproliferative DisordersEBV+ Associated Lymphoma+9 more
Atara Biotherapeutics
Not applicableStudy completedNCT02887599
What this trial is testing

Assessment of the Cytotoxic Immune Status of Pancreatic Cancer Patients and the Severity of the Cancer Using Measurement of Natural Killer Cell Activities

Who this might be right for
Pancreatic Cancer
Yonsei University 203
Testing effectiveness (Phase 2)Study completedNCT00953420
What this trial is testing

Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes

Who this might be right for
Nasopharyngeal Carcinoma
Baylor College of Medicine 20
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Testing effectiveness (Phase 2)UnknownNCT02766348
What this trial is testing

Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients

Who this might be right for
NSCLC
Shenzhen Hornetcorn Bio-technology Company, LTD 60
Testing effectiveness (Phase 2)Ended earlyNCT01431794
What this trial is testing

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 23
Testing effectiveness (Phase 2)UnknownNCT00690872
What this trial is testing

Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Centre, Singapore 35
Early research (Phase 1)Study completedNCT00450502
What this trial is testing

Safety of Batracylin in Patients With Solid Tumors and Lymphomas

Who this might be right for
Neoplasms
National Cancer Institute (NCI) 33
Early research (Phase 1)Study completedNCT00590083
What this trial is testing

Administration of Virus-Specific Cytotoxic T-Lymphocytes

Who this might be right for
Adenovirus Infection
Baylor College of Medicine 14
Early research (Phase 1)Study completedNCT02057445
What this trial is testing

3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma

Who this might be right for
Non-Hodgkins LymphomaHodgkins LymphomaLymphoproliferative Disorder
New York Medical College 1
Testing effectiveness (Phase 2)UnknownNCT03552458
What this trial is testing

Effects of Probiotics in Preventing Oral Mucositis

Who this might be right for
Head-and-neck Cancer
National University Hospital, Singapore 50
Next Page